Nasdaq Biotechnology Ishares (IBB) 330.21 $IBB
3 Biotech Stocks You Don't Have to Babysit
Brian Feroldi, Todd Campbell, and George Budwell, The Motley Fool - Motley Fool - Tue Nov 17, 9:31AM CST
Image by Juliacdrd via pixabay Biotech stocks tend to be a risky breed, since even though they can offer investors strong returns, they usually walk hand in hand with huge volatility. To see this reality in action, look no further than the...
GILD: 104.35 (+0.54), IBB: 330.21 (+5.32), AMGN: 158.77 (+4.27), CELG: 111.53 (+1.39)
iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 2.06%
Comtex SmarTrend(R) - Thu Nov 12, 4:57PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $305.79 to a high of $327.69. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $326.76 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 330.21 (+5.32)
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Rebound after Yesterday's 2.06% Sell Off
Comtex SmarTrend(R) - Thu Nov 12, 4:56PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $305.79 to a high of $327.69. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $326.76 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 330.21 (+5.32)
What Does 2016 Hold for This Closely-Watched Biotech ETF?
George Budwell, The Motley Fool - Motley Fool - Mon Nov 09, 12:49PM CST
The iShares Nasdaq Biotechnology ETF is a quick and easy way to gain exposure to a wide variety of biotech and pharmaceutical equities listed on the NASDAQ. As an added bonus, this ETF is designed to limit the risk of major downward price...
BIIB: 281.79 (-1.74), GILD: 104.35 (+0.54), AMGN: 158.77 (+4.27), IBB: 330.21 (+5.32), REGN: 571.98 (+13.60), CELG: 111.53 (+1.39)
Biotech Sees Better-than-Expected Earnings: ETFs in Focus
Zacks Equity Research - Zacks Investment Research - Fri Nov 06, 10:22AM CST
Driven by better-than-expected results, ETFs having considerable exposure to these five biotech companies have been surging.
BIIB: 281.79 (-1.74), GILD: 104.35 (+0.54), ALXN: 171.02 (+2.11), BBH: 123.80 (+1.83), IBB: 330.21 (+5.32), AMGN: 158.77 (+4.27), CELG: 111.53 (+1.39)
Biotechs Sell Off Hard, But Indexes Cut Their Losses
at Investor's Business Daily - Thu Nov 05, 3:22PM CST
Stocks lifted off their morning lows to finish nearly flat on Thursday, but a fresh batch of corporate earnings still triggered big swings in certain sectors. The S&P 500 closed virtually flat, while the Dow industrials edged 0.1% higher. The Nasdaq...
BOKF: 68.99 (+0.35), IBB: 330.21 (+5.32), RGLD: 34.75 (-1.83), BK: 43.26 (+0.33), CELG: 111.53 (+1.39)
SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 3.87% Gain
Comtex SmarTrend(R) - Mon Nov 02, 3:56PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $326.40 to a high of $338.66. Yesterday, the shares gained 3.9%, which took the trading range above the 3-day high of $336.89 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 330.21 (+5.32)
Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 3.87% Yesterday
Comtex SmarTrend(R) - Mon Nov 02, 3:55PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $326.40 to a high of $338.66. Yesterday, the shares gained 3.9%, which took the trading range above the 3-day high of $336.89 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 330.21 (+5.32)
October ETF Asset-Flow Roundup
Zacks Equity Research - Zacks Investment Research - Mon Nov 02, 11:25AM CST
Let us take a look at the ETFs that pulled in strong assets in October and those that could not.
JNK: 35.60 (+0.05), HYG: 83.62 (+0.23), IEI: 123.09 (-0.05), SPY: 206.31 (+0.69), QQQ: 111.96 (+0.54), LQD: 115.24 (+0.08), IBB: 330.21 (+5.32), EZU: 36.11 (+0.26), IWM: 115.03 (-0.02), SHV: 110.24 (unch)
The Top 3 Biotech ETFs on the Market
Brian Feroldi, The Motley Fool - Motley Fool - Sun Nov 01, 3:09PM CST
Photo by Bill Brooks Flickr Creative Commons. Biotech investing is not for the faint of heart . The industry is chock-full of companies that don't even have revenue yet, let alone profits, which can lead to wild price swings. To make matters...
FBT: 110.06 (+2.04), XBI: 68.73 (+0.58), IBB: 330.21 (+5.32)
3 Biotech Stocks to Buy in November
Brian Feroldi, Todd Campbell, and George Budwell, The Motley Fool - Motley Fool - Sun Nov 01, 12:20PM CST
Image Source TBIT via pixabay Well, that was fast. A month ago it seemed like biotech stocks couldn't do anything right. Shares of the iShares Nasdaq Biotechnology ETF , which holds a huge collection of biotech stocks, were pummeled over fears...
SGYP: 6.06 (-0.02), IRWD: 12.18 (+0.17), ALXN: 171.02 (+2.11), IBB: 330.21 (+5.32), EXEL: 5.65 (+0.17)
Betting Big on Beleaguered Biotechs
at The Street - Thu Oct 29, 3:00PM CDT
Investor's holdings have fallen along with the sector, but he's raising the stakes.
OREX: 2.47 (-0.04), BITI: 13.35 (+0.02), IBB: 330.21 (+5.32), ATRA: 31.44 (+0.38), KERX: 5.11 (unch)
After Yesterday's Rally of 3.21% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Oct 27, 3:57PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $317.74 to a high of $327.65. Yesterday, the shares gained 3.2%, which took the trading range above the 3-day high of $322.21 on volume of 2.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 330.21 (+5.32)
BUYINS.NET: IGV, IYH, VGT, IBB, VHT, IYW Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Oct 27, 7:08AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of iShares S&P North Amer Technology-Software Idx Fd (NYSE:IGV), iShares Dow Jones US Healthcare Sector Index Fund (NYSE:IYH), Vanguard Information Technology Etf (NYSE:VGT), Ishares Nasdaq Biotechnology (NASDAQ:IBB), Vanguard Health Care Etf (NYSE:VHT), iShares Dow Jones US Technology Sector Index Fund (NYSE:IYW) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
IGV: 103.67 (+0.80), IYH: 149.40 (+1.00), IBB: 330.21 (+5.32), VGT: 109.48 (+0.47), VHT: 131.00 (+1.03), IYW: 107.94 (+0.45)
Why Keryx Biopharmaceuticals Was Obliterated in September
Brian Feroldi, The Motley Fool - Motley Fool - Sun Oct 25, 5:01PM CDT
Shares of Keryx Biopharmaceuticals , a drug developer with a focus on renal disease, had an awful month: Shares were down nearly 40% in September. What caused the huge downward move? See the presentation below for details. The next...
IBB: 330.21 (+5.32), KERX: 5.11 (unch)
3 Biotech Stocks You Don't Have to Babysit
Brian Feroldi, Todd Campbell, and George Budwell, The Motley Fool - Motley Fool - Tue Nov 17, 9:31AM CST
Image by Juliacdrd via pixabay Biotech stocks tend to be a risky breed, since even though they can offer investors strong returns, they usually walk hand in hand with huge volatility. To see this reality in action, look no further than the...
GILD: 104.35 (+0.54), IBB: 330.21 (+5.32), AMGN: 158.77 (+4.27), CELG: 111.53 (+1.39)
iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 2.06%
Comtex SmarTrend(R) - Thu Nov 12, 4:57PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $305.79 to a high of $327.69. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $326.76 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 330.21 (+5.32)
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Rebound after Yesterday's 2.06% Sell Off
Comtex SmarTrend(R) - Thu Nov 12, 4:56PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $305.79 to a high of $327.69. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $326.76 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 330.21 (+5.32)
What Does 2016 Hold for This Closely-Watched Biotech ETF?
George Budwell, The Motley Fool - Motley Fool - Mon Nov 09, 12:49PM CST
The iShares Nasdaq Biotechnology ETF is a quick and easy way to gain exposure to a wide variety of biotech and pharmaceutical equities listed on the NASDAQ. As an added bonus, this ETF is designed to limit the risk of major downward price...
BIIB: 281.79 (-1.74), GILD: 104.35 (+0.54), AMGN: 158.77 (+4.27), IBB: 330.21 (+5.32), REGN: 571.98 (+13.60), CELG: 111.53 (+1.39)
Biotech Sees Better-than-Expected Earnings: ETFs in Focus
Zacks Equity Research - Zacks Investment Research - Fri Nov 06, 10:22AM CST
Driven by better-than-expected results, ETFs having considerable exposure to these five biotech companies have been surging.
BIIB: 281.79 (-1.74), GILD: 104.35 (+0.54), ALXN: 171.02 (+2.11), BBH: 123.80 (+1.83), IBB: 330.21 (+5.32), AMGN: 158.77 (+4.27), CELG: 111.53 (+1.39)
Biotechs Sell Off Hard, But Indexes Cut Their Losses
at Investor's Business Daily - Thu Nov 05, 3:22PM CST
Stocks lifted off their morning lows to finish nearly flat on Thursday, but a fresh batch of corporate earnings still triggered big swings in certain sectors. The S&P 500 closed virtually flat, while the Dow industrials edged 0.1% higher. The Nasdaq...
BOKF: 68.99 (+0.35), IBB: 330.21 (+5.32), RGLD: 34.75 (-1.83), BK: 43.26 (+0.33), CELG: 111.53 (+1.39)
SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 3.87% Gain
Comtex SmarTrend(R) - Mon Nov 02, 3:56PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $326.40 to a high of $338.66. Yesterday, the shares gained 3.9%, which took the trading range above the 3-day high of $336.89 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 330.21 (+5.32)
Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 3.87% Yesterday
Comtex SmarTrend(R) - Mon Nov 02, 3:55PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $326.40 to a high of $338.66. Yesterday, the shares gained 3.9%, which took the trading range above the 3-day high of $336.89 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 330.21 (+5.32)
October ETF Asset-Flow Roundup
Zacks Equity Research - Zacks Investment Research - Mon Nov 02, 11:25AM CST
Let us take a look at the ETFs that pulled in strong assets in October and those that could not.
JNK: 35.60 (+0.05), HYG: 83.62 (+0.23), IEI: 123.09 (-0.05), SPY: 206.31 (+0.69), QQQ: 111.96 (+0.54), LQD: 115.24 (+0.08), IBB: 330.21 (+5.32), EZU: 36.11 (+0.26), IWM: 115.03 (-0.02), SHV: 110.24 (unch)
The Top 3 Biotech ETFs on the Market
Brian Feroldi, The Motley Fool - Motley Fool - Sun Nov 01, 3:09PM CST
Photo by Bill Brooks Flickr Creative Commons. Biotech investing is not for the faint of heart . The industry is chock-full of companies that don't even have revenue yet, let alone profits, which can lead to wild price swings. To make matters...
FBT: 110.06 (+2.04), XBI: 68.73 (+0.58), IBB: 330.21 (+5.32)
3 Biotech Stocks to Buy in November
Brian Feroldi, Todd Campbell, and George Budwell, The Motley Fool - Motley Fool - Sun Nov 01, 12:20PM CST
Image Source TBIT via pixabay Well, that was fast. A month ago it seemed like biotech stocks couldn't do anything right. Shares of the iShares Nasdaq Biotechnology ETF , which holds a huge collection of biotech stocks, were pummeled over fears...
SGYP: 6.06 (-0.02), IRWD: 12.18 (+0.17), ALXN: 171.02 (+2.11), IBB: 330.21 (+5.32), EXEL: 5.65 (+0.17)
Betting Big on Beleaguered Biotechs
at The Street - Thu Oct 29, 3:00PM CDT
Investor's holdings have fallen along with the sector, but he's raising the stakes.
OREX: 2.47 (-0.04), BITI: 13.35 (+0.02), IBB: 330.21 (+5.32), ATRA: 31.44 (+0.38), KERX: 5.11 (unch)
After Yesterday's Rally of 3.21% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Oct 27, 3:57PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $317.74 to a high of $327.65. Yesterday, the shares gained 3.2%, which took the trading range above the 3-day high of $322.21 on volume of 2.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 330.21 (+5.32)
BUYINS.NET: IGV, IYH, VGT, IBB, VHT, IYW Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Oct 27, 7:08AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of iShares S&P North Amer Technology-Software Idx Fd (NYSE:IGV), iShares Dow Jones US Healthcare Sector Index Fund (NYSE:IYH), Vanguard Information Technology Etf (NYSE:VGT), Ishares Nasdaq Biotechnology (NASDAQ:IBB), Vanguard Health Care Etf (NYSE:VHT), iShares Dow Jones US Technology Sector Index Fund (NYSE:IYW) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
IGV: 103.67 (+0.80), IYH: 149.40 (+1.00), IBB: 330.21 (+5.32), VGT: 109.48 (+0.47), VHT: 131.00 (+1.03), IYW: 107.94 (+0.45)
Why Keryx Biopharmaceuticals Was Obliterated in September
Brian Feroldi, The Motley Fool - Motley Fool - Sun Oct 25, 5:01PM CDT
Shares of Keryx Biopharmaceuticals , a drug developer with a focus on renal disease, had an awful month: Shares were down nearly 40% in September. What caused the huge downward move? See the presentation below for details. The next...
IBB: 330.21 (+5.32), KERX: 5.11 (unch)
